The Pava Health Tech Report Q1 2026 outlines the key forces shaping the Health Tech industry, including capital concentration, M&A activity, and the continued dominance of AI‑driven business models while providing a strong moat against LLM disruption in the market overall.

Despite slightly moderating deal volumes, investors are doubling down on scalable platforms, proprietary data, and presumed category leaders, while healthcare systems increasingly shift toward prevention, personalization, and digital care ecosystems.

Key trends shaping the market:

• Funding concentration: Venture capital increasingly flows into fewer yet larger rounds resulting in almost doubled average deal value.
• Selective M&A activity: Deal volumes modestly declined, but transaction sizes increased as buyers focused on data‑rich, strategically differentiated assets.
• AI dominance: AI remains the primary value driver across Health Tech, shaping unicorn creation, and large strategic partnerships.
• Wellness and wearables revival: Wellness platforms regained investor momentum, driven by strong demand for continuous health tracking.
• Strategic shift in care delivery: Investors favor companies with proprietary clinical data, as healthcare spending moves toward digital, preventive, and remote care models.
• Remote Patient Monitoring (RPM): RPM benefits from the shift toward digital, preventive, and outpatient care, enabled by continuous, clinical‑grade data capture beyond hospital settings. The report outlines key growth drivers of the RPM market and features industry perspectives from Greta Kreuzer (CEO, cosinuss°) and Markus Wiegmann (Senior Industry Advisor at Pava), alongside expert analysis by Dr. Konstantin Schönborn and Kevin Kissner, both Health Care partners at Pava, on implications for healthcare providers, technology companies, and investors.

Request the Pava Health Tech Report Q1 2026 below. Alternatively, connect directly with our Health Care experts Kevin Kissner, Dr. Lars Veit, and Dr. Konstantin Schönborn to gain strategic insights and a competitive edge.

Our Pava Health Tech Report Q1 2026 is published solely in English.